Huaizhi Wang

Mr. Huaizhi Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2024 in eClinicalMedicine
Verified
Journal Article
Open access
LKLingzhuo Kong
Lingzhuo Kong
HWHuaizhi Wang
Huaizhi Wang
NYNing Yan
Ning Yan
CXChenyue Xu
Chenyue Xu
YCYiqing Chen
Yiqing Chen
SHShaohua Hu
Shaohua Hu
Antipsychotics and mood stabilisers are gathering attention for the disturbance of metabolism. This network meta-analysis aims to evaluate and rank the metabolic effects of the commonly used antipsychotics and mood stabilisers in treating bipolar disorder (BD). Registries including PubMed, Embase, Cochrane Library, Web of Science, Ovid, and Google Scholar were searched before February 15th, 2024, for randomised controlled trials (RCTs) applying antipsychotics or mood stabilisers for BD treatment. The observed outcomes were twelve metabolic indicators. The data were extracted by two reviewers independently, and confirmed by another four reviewers and a corresponding author. The above six reviewers all participated in data analyses. Data extraction was based on PRISMA guidelines, and quality assessment was conducted according to the Cochrane Handbook. Use a random effects model for data pooling. The PROSPERO registration number is CRD42023466669. Together, 5421 records were identified, and 41 publications with 11,678 complete-trial participants were confirmed eligible. After eliminating possible sensitivity, risperidone ranked 1st in elevating fasting serum glucose (SUCRA = 90.7%) and serum insulin (SUCRA = 96.6%). Lurasidone was most likely to elevate HbA1c (SUCRA = 82.1%). Olanzapine ranked 1st in elevating serum TC (SUCRA = 93.3%), TG (SUCRA = 89.6%), and LDL (SUCRA = 94.7%). Lamotrigine ranked 1st in reducing HDL (SUCRA = 82.6%). Amisulpride ranked 1st in elevating body weight (SUCRA = 100.0%). For subgroup analyses, quetiapine is more likely to affect indicators of glucose metabolism among male adult patients with bipolar mania, while long-term lurasidone tended to affect glucose metabolism among female patients with bipolar depression. Among patients under 18, divalproex tended to affect glucose metabolism, with lithium affecting lipid metabolism. In addition, most observed antipsychotics performed higher response and remission rates than placebo, and displayed a similar dropout rate with placebo, while no between-group significance of rate was observed among mood stabilisers. Our findings suggest that overall, antipsychotics are effective in treating BD, while they are also more likely to disturb metabolism than mood stabilisers. Attention should be paid to individual applicability in clinical practice. The results put forward evidence-based information and clinical inspiration for drug compatibility and further research of the BD mechanism. The 10.13039/501100012166 National Key Research and Development Program of China (2023YFC2506200), and the Research Project of Jinan Microecological Biomedicine Shandong Laboratory (No. JNL-2023001B).

2 January 2025 in Neuroscience
Verified
Journal Article
Closed access
XMXinxu Ma
Xinxu Ma
SXShanshan Xue
Shanshan Xue
HMHongzhe Ma
Hongzhe Ma
SSSaboor Saeed
Saboor Saeed
YZYunyun Zhang
Yunyun Zhang
MCMin Cai
Min Cai

3 July 2025 in Annals of Medicine
Verified
Journal Article
Open access
SSSaboor Saeed
Saboor Saeed
HWHuaizhi Wang
Huaizhi Wang
MJMengjie Jia
Mengjie Jia
TLTing Ting Liu
Ting Ting Liu
LXLe Xu
Le Xu
SHShaohua Hu
Shaohua Hu
Anti-NMDAR encephalitis frequently overlaps with demyelinating diseases (MOGAD, NMOSD, MS), creating complex syndromes with diverse presentations and challenging management. Systematic search of databases including MEDLINE, Google Scholar, Embase, Scopus, Cochrane Library, and Web of Science up to March 2024 for studies on co-existing anti-NMDAR encephalitis and demyelinating syndromes. Data extracted on clinical characteristics, diagnostics, treatments, and outcomes. Twenty-five studies identified 256 patients (16.2%) with co-existing Anti-NMDAR encephalitis and demyelinating syndromes, primarily MOGAD (94.5%), with fewer cases involving NMOSD or MS. The Anti-NMDAR + MOGAD subgroup exhibited seizures (51-72.7%), psychiatric symptoms (45.5-71.4%), cognitive dysfunction (30.6%), and movement disorders (30.6%). All patients had CSF anti-NMDAR antibodies, with MOG (60%) or AQP4 (25%) antibodies. Use of standardized, cell-based assays and adherence to established criteria are essential to avoid false positives, particularly for MOG. MRI abnormalities were seen in 75% of patients. First-line immunotherapies were effective in 70% of cases; 80% of refractory cases responded to second-line therapies. Anti-NMDAR encephalitis overlapping with demyelinating diseases is challenging. Tailored treatments based on detailed immune profiles are key to better outcomes.

25 April 2024 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
YPYanmeng Pan
Yanmeng Pan
HWHuaizhi Wang
Huaizhi Wang
YGYimeng Geng
Yimeng Geng
JLJianbo Lai
Jianbo Lai
SHShaohua Hu
Shaohua Hu
Individuals with bipolar disorder (BD) have a greater suicide risk than the general population. In this study, we employed latent profile analysis (LPA) to explore whether Chinese individuals with different phases of BD differed at the levels of suicidal ideation. We recruited 517 patients. Depressive symptoms were measured using the 24-item Hamilton Depression Rating Scale (HAMD-24), and manic symptoms were evaluated using the Young Mania Rating Scale (YMRS). The extent of suicidal thoughts was determined through the Beck Scale for Suicide Ideation (BSSI). The scores of HAMD and YMRS were used to perform LPA. LPA categorized participants into three classes: one exhibiting severe depressive and mild manic symptomatology, another showing severe depressive and severe manic symptomatology, and the third one displaying severe depressive and intermediate manic symptomatology. Suicidal ideation levels were found to be remarkably elevated across all three classes. Additionally, the three classes showed no significant differences in terms of suicidal ideation. Our research confirms the link between depressive symptoms and suicide, independent of the manic symptoms. These findings carry meaning as they provide insight into the suicide risk profiles within different phases of BD.

6 September 2025 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SSSaboor Saeed
Saboor Saeed
HWHuaizhi Wang
Huaizhi Wang
LKLingzhuo Kong
Lingzhuo Kong
YGYimeng Geng
Yimeng Geng
JZJinyu Zhang
Jinyu Zhang
SHShaohua Hu
Shaohua Hu

2 February 2026 in Bipolar Disorders
Verified
Journal Article
Closed access
SSSaboor Saeed
Saboor Saeed
ZLZeyu Luo
Zeyu Luo
HWHuaizhi Wang
Huaizhi Wang
LXLe Xu
Le Xu
XZXuhong Zhang
Xuhong Zhang
SHShaohua Hu
Shaohua Hu